Grupo Hospitalario Quirónsalud

Grupo Hospitalario Quirónsalud - Overview

• Differentiated circuits to be able to attend patients as safely as possible.
• Telemedicine. Non-face-to-face consultations via telephone, videoconference or chat have been imposed during the pandemic.
• Thermal imaging cameras that, using an infrared ray system, allow people with fever to be detected automatically.
• Disinfection with pioneering cold aerosolization systems, capable of generating a mist consisting of 1 billion microdrops of disinfectant dissolved in water and using air as a driving force.
• Disinfection with ultraviolet C and UVC technology.

On the other hand, we would like to share some figures that speak for themselves of the collective effort that the Quirónsalud Group has made to date to respond to this crisis:

1. Around 15,000 patients have been admitted by COVID-19 to Group hospitals (among them, 1,400 in ICU beds), which represents approximately 1 in 8 hospitalized patients in Spain, about 13% of the total, a percentage significantly higher than what would correspond to the Group for its number of beds. In the most affected places, such as Madrid and Barcelona, ​​almost 1 in 5 hospitalized have been treated. Also including many vulnerable and elderly patients.
2. In the first weeks of the crisis, 1,400 additional beds were added, including 400 new ICU beds (doubling the company's initial capacity) and 140 beds in a medicalized hotel. In addition, around 350 new respirators were incorporated (including 30 that were shipped from Germany), in a context of great international shortage.
3. Additionally, almost 2,000 new staff hires were made to respond to both the avalanche of patients and the sick leave that we have had, and nearly 250 volunteers from our centers traveled throughout Spain to support the most critical moments in Madrid and Barcelona.
4. Diagnostic kits (both PCR and antibodies) have multiplied and more than 3.5 million protective kits (including 2.5 million masks) have been purchased, including 2 ambulances purchased to move patients quickly between our hospitals .
5. The Group was the first to carry out massive tests on the entire workforce of 40,000 employees.
6. Digital consultations have accelerated and, during this crisis, we have exceeded 2 million users on the Patient Portal. Clearly, digitization is here to stay.

• 1 proton therapy center
• 5 Da-Vinci robotic surgery systems
• 1 Gamma Knife radiosurgery system
• 1 CyberKnife radiosurgery system
• 21 linear accelerator systems for radiotherapy
• 11 PET-CT scanners
• 81 MRIs

The group has, among others, the following hospitals, located in the main cities of Spain. All of them have international airport services within 30 miles (50 Kms) and have professional staff ready to assist and provide first class care to international patients coming from all over the world:

• Hospital Quirónsalud TEKNON
• Institut Omiq Oftalmologia Medica
• Hospital Quirónsalud Barcelona
• Hospital Quirónsalud Marbella
• Hospital Quirónsalud Malaga
• Hospital Quirónsalud Torrevieja
• Hospital Quirónsalud Valencia
• Hospital Universitario Quirónsalud Madrid
  
• Hospital General de Catalunya
• Hospital Ruber Internacional

• Clinical trials: 1001 research studies, of which 649 are clinical trials and 352 are epidemiological observational studies, with a total amount 1.224 research projects and 967 scientific publications.
• R&D initiatives taking place in virtually all regions where the company is present.
• Hospital Universitario Fundación Jiménez Díaz and its Health Research Institute is the only ministry-certified institute of its kind in a privately managed health center in Spain.
• The group currently has seven university hospitals.